Association of HIV infection, hepatitis C virus infection, and metabolic factors with liver stiffness measured by transient elastography
- PMID: 23901097
- PMCID: PMC3814832
- DOI: 10.1093/infdis/jit357
Association of HIV infection, hepatitis C virus infection, and metabolic factors with liver stiffness measured by transient elastography
Abstract
Background: Few studies have examined the relationship of human immunodeficiency virus (HIV) monoinfection and its associated perturbations with liver fibrosis.
Methods: USING multivariable linear regression, we examined the demographic, behavioral, metabolic and viral factors associated with transient elastography-measured liver stiffness in 314 participants (165 HIV positive/hepatitis C virus [HCV] negative, 78 HIV positive/HCV positive, 14 HIV negative/HCV positive, 57 HIV negative/HCV negative) in the Women's Interagency HIV Study.
Results: Compared with HIV negative/HCV negative women, HIV positive/HCV positive women had higher median liver stiffness values (7.1 vs 4.4 kPa; P < .001); HIV positive/HCV negative and HIV negative/HCV negative women had similar liver stiffness values (both 4.4 kPa; P = .94). HIV/HCV coinfection remained associated with higher liver stiffness values (74% higher; 95% confidence interval [CI], 49-104) even after multivariable adjustment. Among HCV positive women, waist circumference (per 10-cm increase) was associated with 18% (95% CI, 7.5%-30%) higher liver stiffness values after multivariable adjustment; waist circumference showed little association among HIV positive/HCV negative or HIV negative/HCV negative women. Among HIV positive/HCV negative women, history of AIDS (13%; 95% CI, 4% -27%) and HIV RNA (7.3%; 95% CI, 1.59%-13.3%, per 10-fold increase) were associated with greater liver stiffness.
Conclusions: HCV infection but not HIV infection is associated with greater liver stiffness when infected women are compared with those with neither infection. Our finding that waist circumference, a marker of central obesity, is associated with greater liver stiffness in HIV/HCV-coinfected but not HIV-monoinfected or women with neither infection suggests that in the absence of HCV-associated liver injury the adverse effects of obesity are lessened.
Keywords: HCV; HIV; liver fibrosis; obesity; transient elastography; women.
Figures


Similar articles
-
Association of HIV, hepatitis C virus and liver fibrosis severity with interleukin-6 and C-reactive protein levels.AIDS. 2015 Jul 17;29(11):1325-33. doi: 10.1097/QAD.0000000000000654. AIDS. 2015. PMID: 25870985 Free PMC article.
-
Association of HIV, Hepatitis C Virus, and Liver Fibrosis Severity With the Enhanced Liver Fibrosis Score.J Infect Dis. 2016 Apr 1;213(7):1079-86. doi: 10.1093/infdis/jiv567. Epub 2015 Nov 29. J Infect Dis. 2016. PMID: 26621911 Free PMC article.
-
Contribution of Liver Fibrosis and Microbial Translocation to Immune Activation in Persons Infected With HIV and/or Hepatitis C Virus.J Infect Dis. 2018 Mar 28;217(8):1289-1297. doi: 10.1093/infdis/jix688. J Infect Dis. 2018. PMID: 29304196 Free PMC article.
-
Liver Fibrosis Evaluation Using Real-time Shear Wave Elastography in Hepatitis C-Monoinfected and Human Immunodeficiency Virus/Hepatitis C-Coinfected Patients.J Ultrasound Med. 2016 Jun;35(6):1299-308. doi: 10.7863/ultra.15.08066. Epub 2016 May 5. J Ultrasound Med. 2016. PMID: 27151906
-
HCV/ HIV co-infection: time to re-evaluate the role of HIV in the liver?J Viral Hepat. 2008 May;15(5):323-30. doi: 10.1111/j.1365-2893.2008.00970.x. Epub 2008 Jan 17. J Viral Hepat. 2008. PMID: 18208497 Free PMC article. Review.
Cited by
-
Association of HIV, hepatitis C virus and liver fibrosis severity with interleukin-6 and C-reactive protein levels.AIDS. 2015 Jul 17;29(11):1325-33. doi: 10.1097/QAD.0000000000000654. AIDS. 2015. PMID: 25870985 Free PMC article.
-
Association of HIV, Hepatitis C Virus, and Liver Fibrosis Severity With the Enhanced Liver Fibrosis Score.J Infect Dis. 2016 Apr 1;213(7):1079-86. doi: 10.1093/infdis/jiv567. Epub 2015 Nov 29. J Infect Dis. 2016. PMID: 26621911 Free PMC article.
-
Hepatitis C in human immunodeficiency virus co-infected individuals: Is this still a "special population"?World J Hepatol. 2015 Jul 28;7(15):1936-52. doi: 10.4254/wjh.v7.i15.1936. World J Hepatol. 2015. PMID: 26244068 Free PMC article. Review.
-
Contribution of Liver Fibrosis and Microbial Translocation to Immune Activation in Persons Infected With HIV and/or Hepatitis C Virus.J Infect Dis. 2018 Mar 28;217(8):1289-1297. doi: 10.1093/infdis/jix688. J Infect Dis. 2018. PMID: 29304196 Free PMC article.
-
HIV, Aging, and Viral Coinfections: Taking the Long View.Curr HIV/AIDS Rep. 2016 Oct;13(5):269-78. doi: 10.1007/s11904-016-0327-7. Curr HIV/AIDS Rep. 2016. PMID: 27614654 Review.
References
-
- Salmon-Ceron D, Lewden C, Morlat P, et al. Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol. J Hepatol. 2005;42:799–805. - PubMed
-
- Weber R, Sabin C, Friis-Moller N, et al. Liver-related deaths in persons infected with the human immunodeficiency virus: the D: A: D study. Arch Intern Med. 2006;166:1632–41. - PubMed
-
- Bani-Sadr F, Carrat F, Bedossa P, et al. Hepatic steatosis in HIV-HCV coinfected patients: analysis of risk factors. AIDS. 2006;20:525. - PubMed
-
- Benhamou Y, Bochet M, Di Martino V, et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. Hepatology. 1999;30:1054–8. - PubMed
-
- Rodriguez-Guardado A, Maradona JA, Asensi V, Cartón JA, Casado L. Hepatitis C virus in patients with HIV infection and lipodystrophy. J Acquir Immune Defic Syndr. 2003;32:348–9. - PubMed
Publication types
MeSH terms
Grants and funding
- UO1-HD-32632/HD/NICHD NIH HHS/United States
- M01 RR000079/RR/NCRR NIH HHS/United States
- UO1-AI-34994/AI/NIAID NIH HHS/United States
- UO1-AI-34989/AI/NIAID NIH HHS/United States
- U01 AI034989/AI/NIAID NIH HHS/United States
- M01 RR000071/RR/NCRR NIH HHS/United States
- UO1-AI-35004/AI/NIAID NIH HHS/United States
- UO1-AI-34993/AI/NIAID NIH HHS/United States
- U01 AI034994/AI/NIAID NIH HHS/United States
- R01 AI087176/AI/NIAID NIH HHS/United States
- UO1-AI-42590/AI/NIAID NIH HHS/United States
- U01 AI034993/AI/NIAID NIH HHS/United States
- MO1-RR-00083/RR/NCRR NIH HHS/United States
- U01 AI031834/AI/NIAID NIH HHS/United States
- U01 AI035004/AI/NIAID NIH HHS/United States
- P30 DK026743/DK/NIDDK NIH HHS/United States
- R01 AI 087176/AI/NIAID NIH HHS/United States
- MO1-RR-00079/RR/NCRR NIH HHS/United States
- UO1-AI-31834/AI/NIAID NIH HHS/United States
- M01 RR000083/RR/NCRR NIH HHS/United States
- MO1-RR-00071/RR/NCRR NIH HHS/United States
- U01 HD032632/HD/NICHD NIH HHS/United States
- U01 AI042590/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical